Faster global financial news!
Shanghai Allist Pharmaceuticals
-
ArriVent BioPharma's shares plummeted nearly 47% after its China-licensed cancer drug failed a late-stage trial.
Shares of U.S. biopharmaceutical company ArriVent BioPharma plummeted nearly 47% on Tuesday after it reported that firmonertinib, a cancer treatment licensed from Shanghai Allist Pharmaceuticals in Ch
-
ArriVent BioPharma's shares plummeted nearly 47% after its China-licensed cancer drug failed a late-stage trial.
Shares of U.S. biopharmaceutical company ArriVent BioPharma plummeted nearly 47% on Tuesday after it reported that firmonertinib, a cancer treatment licensed from Shanghai Allist Pharmaceuticals in Ch
- No data
Shanghai Allist Pharmaceuticals
24H Trending
-
1
House China Committee Chair Urges Fed to Review Hong Kong's Dollar Lifeline Access
-
2
Morgan Stanley Report: AI Memory Bottlenecks Create New Investment Opportunities, CXL Market Forecast Raised to $6 Billion by 2030, Recommends Beneficiary Stocks Such as Astera Labs, Marvell, and Cerebras
-
3
Southeast Asian energy ministers are meeting this week to discuss regional energy security against the backdrop of the war in Iran.
-
4
U.S. Democratic senators have sent a letter to Treasury Secretary Scott Bessent and other senior officials, demanding disclosure of the AI regulatory framework revision process and questioning the influence of tech giant lobbying on policy.
-
5
ECB Chief Economist Lane: AI is the biggest global issue, driving world trade and leading to rising US Treasury yields.
-
6
Exchange Fund Bills Tender Results
-
7
AI startup Hark launches personal AI assistant Hark Pro, emphasizing privacy protection.
-
8
Anduril plans to invest $3.7bn in a new shipyard to manufacture parts for US Navy's top submarines, as Trump seeks to reduce dependence on prime contractors.
-
9
OKX has secured new investments from Ripple, Circle, Standard Chartered, and others, reaching a valuation of $25 billion, and has formed a joint venture with ICE to launch tokenized stock trading.
-
10
US yields fall from 2002 high; Bessent addresses debt
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
